Larson Financial Group’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$321 Sell
78
-4,836
-98% -$23.4K ﹤0.01% 3390
2025
Q4
$32.7K Buy
4,914
+2,837
+137% +$19.2K ﹤0.01% 1444
2025
Q3
$12.8K Buy
2,077
+1,991
+2,315% +$15.5K ﹤0.01% 1894
2025
Q2
$792 Sell
86
-1,592
-95% -$16.3K ﹤0.01% 2724
2025
Q1
$20.2K Hold
1,678
﹤0.01% 1364
2024
Q4
$18.5K Buy
1,678
+1,000
+147% +$14.1K ﹤0.01% 1247
2024
Q3
$11K Hold
678
﹤0.01% 1447
2024
Q2
$7.36K Buy
+678
New +$8.34K ﹤0.01% 1347

Other funds holding EOLS

Larson Financial Group's EOLS Position: Q1 2026 in Review

Larson Financial Group reduced its Evolus (EOLS) stake by 98% in Q1 2026, selling an estimated $23.4K and leaving 78 shares worth $321. The position accounts for ﹤0.01% of the portfolio, ranked #3390.

Larson Financial Group first reported a position in EOLS in Q2 2024 and has held it in 8 quarters since. The position peaked at $32.7K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Larson Financial Group held 78 shares of Evolus worth $321 as of Q1 2026.
  • Larson Financial Group sold 4,836 Evolus shares in Q1 2026, an estimated $23.4K.
  • Evolus made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3390 holding.
  • Larson Financial Group first reported a position in Evolus in Q2 2024 and has held it in 8 quarters since.
  • Larson Financial Group's Evolus position peaked at $32.7K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.